CohBar, Inc(NASDAQ:CWBR) 
CohBar, Inc., a clinical stage biotechnology company, focuses in the research and development of mitochondria based therapeutics (MBTs) for the treatment of chronic and age-related diseases. The company develops MBTs to treat non-alcoholic steatohepatitis (NASH), obesity, fatty liver disease, idiopa...
Website: http://www.cohbar.com
Founded: 2007
Full Time Employees: 12
Sector: Healthcare
Industry: Biotechnology
The information provided in this report is taken from www.sec.gov. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.
Day
Week
Month
Date 2024-07-22
P
O 0.24
H 0.24
L 0.24
C 0.24
V 0
10EMA 0.24
20EMA 0.24
60EMA 0.24
120EMA 0.24
250EMA 0.24